Key result
Bioprosthetic valve degeneration shares a similar underlying pathology with native aortic valves, with inflammatory and repair processes playing a prominent role in bioprostheses.
The degeneration of bioprosthetic tissue valves shares similar pathological mechanisms with native aortic valve stenosis, particularly involving inflammatory and repair processes.
Answers are grounded in this paper and cite their sources.
Suggests inflammation as potential target in bioprosthetic degeneration; confirms shared pathology but leaves open clinical translation.
Aortic stenosis (AS) is the most common valvular disease requiring valve replacement with a prevalence of 2-4% in adults greater than or equal to 65 years of age. There is increasing evidence that AS is an active inflammatory process that is highly regulated, displaying multiple hallmarks of atherosclerosis. Clinically, the definite therapy of advanced AS is prosthetic valve replacement. Herein, bioprosthetic tissue valves (BPs) possess superior thromboresistant and hemodynamic properties compared with mechanical valves. However, cusp degeneration and calcification also limit their long-term outcome. The pathogenesis of BP calcification as well as that of native valves is still poorly understood. Recent studies suggest a similar valvular pathology, that underlies both types of valvular degeneration, but also an even more important role of inflammatory and repair processes in the case of BP degeneration.
No takes yet. Share an insight, caveat, or question.
Skowasch et al. (2006) conducted a review in Aortic stenosis. Bioprosthetic tissue valves vs. Native aortic valves was evaluated. Bioprosthetic valve degeneration shares a similar underlying pathology with native aortic valves, with inflammatory and repair processes playing a prominent role in bioprostheses.
Synapse has enriched 10 related papers. Consider them for comparative context: